Form 4: Guardant Health Executive Terilyn J. Monroe Reports Stock Transactions

Chief People Officer Terilyn J. Monroe reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to her beneficial ownership of Guardant Health stock.

Summary

• On March 1, 2025, Terilyn J. Monroe, Chief People Officer of Guardant Health, Inc., engaged in transactions involving the company's common stock.
• A portion of performance-based restricted stock units vested, resulting in the acquisition of 14,894 shares.
• 6,565 shares were withheld by the company to cover tax obligations related to the vesting of the restricted stock units at a price of $42.55.
• Following these transactions, Monroe directly owns 20,257 shares of common stock and 29,794 performance-based restricted stock units.

Sentiment

Score: 6

Explanation: Neutral sentiment as the document primarily reports routine stock transactions related to executive compensation. The vesting of restricted stock units suggests achievement of performance metrics, which is mildly positive.

Positives

• The vesting of restricted stock units indicates that performance metrics were achieved, which is a positive signal.

Future Outlook

The remaining 67% of the performance-based restricted stock units will vest in two installments: 33% on January 1, 2026, and 34% on January 1, 2027.

Industry Context

Executive stock transactions are common and provide insights into management's perspective on the company's performance and future prospects. Vesting of restricted stock units often ties executive compensation to company performance.

Stakeholder Impact

• The vesting of restricted stock units aligns executive interests with shareholder value.

Key Dates